Latest news for Ormand Inds (OTC:OMDD) Stock

ORMAND INDUSTRIES INC by Ormand Industries, Inc.

Ormand Inds Inc

WIIM

FPAY

FlexShopper shares are trading higher after the company provided a monthly business update for January and reported month-over-month growth for key operational metrics.

Steel and aluminum stocks jumped Monday in premarket trading after President Donald Trump said he would reintroduce 25% tariffs <a href="https://www.benzinga.com/topic/metals">on imported metals</a>.
The move aims to reshape global trade <a href="https://www.benzinga.com/news/econ-s">and revive domestic production</a>, but also reignites trade tensions that defined his first term.
What Happened: In a statement aboard Air Force One on Sunday, Trump said the tariffs would apply to all countries, without specifying when they would take effect.
Markets reacted swiftly, with shares of major American steel and aluminum producers rallying ahead of the opening bell
Steel and aluminum stocks soared in premarket trading as investors quickly priced in the potential benefits for domestic metal producers.
Century Aluminum Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) gained 10.4%, Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) climbed 7.2%, and Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) rose 7%. Alcoa Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) up 5.2% and Kaiser Aluminum Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) gained 2.5%. 
United States Steel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>), which has faced pressure from foreign competition, advanced 4.3%, while Steel Dynamics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) added 5.4%.
Read Also: <a href="https://www.benzinga.com/25/02/43587918/donald-trumps-expected-tariffs-on-aluminum-steel-imports-may-impact-domestic-companies-heres-a-list-of-metal-etfs-that-could-be-affected">Donald Trump&#8217;s Expected Tariffs On Aluminum, Steel Imports May Impact Domestic Companies: Here&#8217;s A List Of Metal ETFs That Could Be Affected</a>
Why It Matters: Tariffs have major implications for U.S. manufacturers, foreign exporters, and global supply chains. They also risk retaliatory measures from key U.S. trading partners.
Trump first imposed tariffs on steel and aluminum in 2018, citing national security concerns. Those duties—25% on steel and 10% on aluminum—aimed to protect domestic manufacturers from what he called unfair competition, particularly from China.
The policy sparked backlash from U.S. allies, including Canada and Mexico, but also drove up prices, boosting profits for domestic producers.
U.S. Census Bureau data shows that in 2024, the U.S. imported: 
<ul>
<li>$11.2 billion worth of steel from Canada; $9.5 billion worth of aluminum</li>
<li>$6.5 billion from Mexico; just under $1 billion in aluminum from Mexico.</li>
</ul>
&#8220;Canadian steel and aluminum support key industries in the U.S., from defense and shipbuilding to auto manufacturing,&#8221; Canadian Innovation Minister Francois-Philippe Champagne posted on X, adding that &#8220;We will continue to defend Canada, our workers and our industries.&#8221;
European steelmakers warned that tariffs could push excess global supply toward their markets.
&#8220;The measures would lead to further volume diversions to Europe, increasing import pressure due to overcapacity from China and other countries,&#8221; said Olaf Reinecke, CEO of German steelmaker Salzgitter.
What&#8217;s Next: Trump indicated plans to introduce reciprocal tariffs in the coming days, matching rates imposed by other countries on U.S. goods. These measures could take effect almost immediately.
&#8220;After the back and forth on Canada and Mexico tariffs, markets have distanced themselves from trading any tariff announcements,&#8221; said Robin Brooks, economist at the Brookings Institution. &#8220;Tariffs are not priced.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">After the back and forth on Canada and Mexico tariffs, markets have distanced themselves from trading any tariff announcements. So last night&#39;s news of steel and aluminum tariffs &#8211; which hit Canada and Mexico significantly &#8211; is largely being ignored. Tariffs are NOT priced&#8230; <a href="https://t.co/QfV67R3bN7">pic.twitter.com/QfV67R3bN7</a>
&mdash; Robin Brooks (@robin_j_brooks) <a href="https://twitter.com/robin_j_brooks/status/1888934023549854054?ref_src=twsrc%5Etfw">February 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43574215/trumps-tax-plans-could-slash-revenue-by-11-trillion">Trump&#8217;s Tax Plans Could Push Debt To 149% Of GDP: Report Says White House Relies On &#8216;Fantasy Math&#8217;</a></li>
</ul>
Image: Shutterstock

Analyst Color

Government

Macro Economic Events

Regulations

Politics

Global

Econ #s

Economics

CENX

KALU

STLD

US Steel, Aluminum Stocks Rally As Trump Revives 25% Tariff Plan

Guggenheim analyst Vamil Divan reiterates Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) with a Buy and maintains $33 price target.

News

Price Target

Reiteration

Analyst Ratings

Guggenheim Reiterates Buy on Pfizer, Maintains $33 Price Target

Guggenheim analyst Yatin Suneja maintains Neurocrine Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) with a Buy and lowers the price target from $165 to $163.

NBIX

Guggenheim Maintains Buy on Neurocrine Biosciences, Lowers Price Target to $163

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">IMPINJ Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>)</h3>
<ul>
<li>On Feb. 5, Impinj reported worse-than-expected fourth-quarter sales results and issued first-quarter revenue guidance below estimates. The company' stock fell around 27% over the past month and has a <a href="https://www.benzinga.com/quote/PI">52-week low of $97.77</a>.</li>
<li>RSI Value: 22.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>PI Price Action: Shares of IMPINJ fell 2.2% to close at $105.38 on Friday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1">latest PI news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="915" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10084947/image-77.png" alt="" class="wp-image-774578" style="width:485px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10084947/image-77.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10084947/image-77-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10084947/image-77-768x707.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<h3 class="wp-block-heading">Xerox Holdings Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>)&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Jan. 28, Xerox reported worse-than-expected fourth-quarter adjusted EPS results.. The company's stock fell around 13% over the past month and <a href="https://www.benzinga.com/quote/XRX">has a 52-week low</a> of $7.81.</li>
<li>RSI Value: 29.3</li>
<li>XRX Price Action: Shares of Xerox dipped 6.4% to close at $7.85 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1">XRX stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="923" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085215/image-78.png" alt="" class="wp-image-774585" style="width:553px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085215/image-78.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085215/image-78-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085215/image-78-768x707.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></a></figure>
<h3 class="wp-block-heading">Zebra Technologies Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>)</h3>
<ul>
<li>Zebra Technologies will report its fourth quarter and full year 2024 financial results on Thursday, Feb. 13. The company's stock fell around 5% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/ZBRA">low of $243.48.</a></li>
<li>RSI Value: 28.5</li>
<li>ZBRA Price Action: Shares of Zebra fell 3.6% to close at $363.44 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1">ZBRA shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="875" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085319/image-79.png" alt="" class="wp-image-774586" style="width:516px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085319/image-79.png 875w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085319/image-79-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10085319/image-79-768x730.png 768w" sizes="(max-width: 875px) 100vw, 875px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

ZBRA

Top 3 Tech Stocks That May Jump This Month

BTAI

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

General

Acting Director Of U.S. Consumer Financial Protection Bureau Instructs All Staff Not To Perform 'Any Work Task,' Email Says

CSP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSPI#NASDAQ">CSPI</a>) reported quarterly earnings of $0.05 per share. This is a 350 percent increase over losses of $(0.02) per share from the same period last year. The company reported $15.67 million in sales this quarter. This is a 1.92 percent increase over sales of $15.38 million the same period last year.

Earnings

CSPI

CSP Q1 EPS $0.05 Up From $(0.02) YoY, Sales $15.67M Up From $15.38M YoY

Shares of fast-food chain McDonald&#8217;s Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) are trading higher in <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">premarket on Monday</a>.
The company reported a fourth-quarter sales decline of 0.3% year-on-year to $6.388 billion, missing the analyst consensus estimate of $6.442 billion.
Global comparable sales increased 0.4%, while U.S. comparable sales slipped 1.4%.
Comparable sales for International Operated Markets segment increased 0.1% and the International Developmental Licensed Markets segment improved 4.1%.
Systemwide sales increased&nbsp;2%&nbsp;(2%&nbsp;in constant currencies).
Sales by company-owned and operated restaurants dropped 7% to $2.3 billion, while sales from franchised restaurants grew 2% at $3.95 billion.
Systemwide sales to loyalty members across 60 loyalty markets were over $30 billion for the twelve-month period and approximately $8 billion for the quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43570221/analysts-see-positive-momentum-for-expedia-on-strong-q4-earnings" rel="noreferrer noopener">Expedia&#8217;s Travel Momentum Grows, But Analysts Await Clearer Signs Of Long-Term Upside</a>
90-day active loyalty users were over 175 million across 60 loyalty markets as of year-end, with growth of about 15% Y/Y.
Total operating costs and expenses decreased 2% to $3.52 billion. Operating income for the quarter climbed 2% to $2.86 billion, with an operating margin of 44.9% compared to 43.7% last year.
Adjusted EPS of $2.83 was in line with the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">analyst consensus estimate.</a>
The company held $1.08 billion in cash and equivalents as of December 31, 2024. Operating cash flow for twelve months totaled $9.44 billion with a free cash flow of $6.67 billion.
&#8220;Accelerating the Arches continues to be the right strategy as we focus on growing market share,&#8221; said CEO Chris Kempczinski.
&#8220;We&#8217;re playing to win, focusing on our customers with outstanding value, exciting menu innovation and culturally relevant marketing.&#8221;&nbsp;
Price Action: MCD shares are trading higher by 1.46% at $298.61 in premarket at the last check Monday.
Read Next:<a target="_blank" href="https://www.benzinga.com/25/02/43563232/software-company-solarwinds-to-go-private-in-44b-deal-stocks-skyrocket" rel="noreferrer noopener"></a>
<ul>
<li><a href="https://www.benzinga.com/25/02/43563232/software-company-solarwinds-to-go-private-in-44b-deal-stocks-skyrocket" target="_blank" rel="noreferrer noopener">Software Company SolarWinds Agrees To Go Private In $4.4B Deal</a></li>
</ul>
Image via Shutterstock.

Equities

Movers

McDonald's Q4 Earnings: Stagnant Revenue Growth, US Comp Sales Decline And More

Alexander's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALX#NYSE">ALX</a>) reported its Q4 earnings results on Monday, February 10, 2025 at 08:32 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Alexander's beat estimated earnings by 9.0%, reporting an EPS of $4.06 versus an estimate of $3.71.
Revenue was down $7.03 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
During the previous quarter, the company beat on EPS by $0.27, leading to a 4.0% increase share price change the next day.

To track all earnings releases for Alexander's <a href="https://www.benzinga.com/quote/ALX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Alexander's Q4 Earnings

Offerings

FTEL

Fitell Updated Registered Direct Offering For Up To $10.0M To Purchase Up To 1,195,220 Shares In The Form Of Warrants At $5.02/Share

Biotech

PALI

Palisade Bio Announces Preclinical Data Of PALI-2108 In Reducing Colitis Symptoms In DSS Mouse Model; Advancing To Phase 1a/b Study With Favorable Safety; Data Presented At 2025 Crohn's And Colitis Congress

BDRX

Biodexa Pharmaceuticals shares are trading higher after the company announced it received FDA fast-track designation for eRapa.

Guggenheim analyst Yatin Suneja maintains Immunovant (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMVT#NASDAQ">IMVT</a>) with a Buy and lowers the price target from $46 to $44.

IMVT

Guggenheim Maintains Buy on Immunovant, Lowers Price Target to $44

The <a href="https://womengrow.com/">Women Grow Leadership Summit 2025</a> is gearing up to be a defining moment for cannabis entrepreneurs, industry experts and advocates. Set against the backdrop of the Gaylord National Resort and Convention Center in National Harbor, Maryland, this two-day event (Feb. 17-18, 2025) promises a mix of high-profile speakers, networking opportunities and sector-specific workshops, all designed to ignite business growth and advocacy in cannabis.
<h3 class="wp-block-heading">A Summit Where Deals Happen</h3>
The Women Grow Leadership Summit 2025 is all about action. Designed to facilitate deal flow for license holders and emerging entrepreneurs, the event will feature matchmaking sessions, expert-led discussions and interactive tracks focused on business strategy, investment and policy.
Dr. Chanda Macias, CEO of Women Grow, emphasizes the movement behind the event. "The Women Grow Leadership Summit is more than just an event—it's a movement. Together, we will shape the future of cannabis and empower women across the globe."
<h3 class="wp-block-heading">Star-Studded Speaker Lineup</h3>
Some of the biggest names in sports, cannabis and business are headlining the summit. Brittney Griner, three-time Olympic gold medalist and six-time WNBA All-Star, will take the stage with a keynote titled "Cultivating Change: Empowering Women through Personal Leadership." The basketball star has been a fierce advocate for cannabis reform, speaking out about its role in healthcare and justice reform.
Also joining the conversation is Ricky Williams, the NFL icon turned cannabis entrepreneur who will host a fundraiser for cannabis access advocacy. Williams, known for his pioneering stance on cannabis use in professional sports, will discuss policy reform, athlete wellness and the road ahead for legalization.
<h3 class="wp-block-heading">Networking Meets Celebration</h3>
Beyond panel discussions, the summit fosters direct connections between industry leaders and aspiring entrepreneurs.
<ul>
<li>Day 1: Features a Careers in Cannabis job fair, expert-led panels and the Mardi Gras celebration, a high-energy networking event.</li>
<li>Day 2: Attendees can choose from curated tracks like Cooking with Cannabis and Business of Cannabis.</li>
</ul>
This year's event also takes place just minutes from Washington, D.C., making it an ideal platform for policy discussions with lawmakers and industry regulators.
<h3 class="wp-block-heading">Why Attend?</h3>
With major industry shifts and policy advancements on the horizon, Women Grow 2025 provides a front-row seat to the future of cannabis. The event offers:
<ul>
<li>High-level insights from top cannabis CEOs, investors, and policymakers.</li>
<li>Business matchmaking and networking with key players.</li>
<li>Workshops tailored to cannabis entrepreneurs at every level.</li>
<li>A chance to support advocacy initiatives for cannabis legalization and women's rights.</li>
</ul>
Whether you&#8217;re a seasoned operator, a first-time entrepreneur, or an industry advocate, this summit is designed to connect, inspire and empower.
<h2 class="wp-block-heading">Keynote Speakers</h2>
<h3 class="wp-block-heading">Brittney Griner</h3>
Three-time Olympic gold medalist and six-time WNBA All-Star.
<ul>
<li>Keynote: "Cultivating Change: Empowering Women through Personal Leadership"</li>
<li>Topics: Legalization, healthcare rights, gender equity.</li>
</ul>
<h3 class="wp-block-heading">Ricky Williams</h3>
NFL icon and founder of Project Champion.
<ul>
<li>Hosting a fundraiser to advocate for cannabis access and policy reform.</li>
<li>Topics: Cannabis in sports, wellness, and legalization advocacy.</li>
</ul>
<h2 class="wp-block-heading">Speakers</h2>
<h3 class="wp-block-heading">Dr. Chanda Macias</h3>
CEO, Women Grow
<h3 class="wp-block-heading">Gail Rand</h3>
CEO / Founder of Grand Consulting
<h3 class="wp-block-heading">Wanda James</h3>
CEO, Simply Pure
<h3 class="wp-block-heading">Maureen McNamara</h3>
Founder &amp; CEO, Cannabis Trainers
<h3 class="wp-block-heading">Jazmin Hupp</h3>
Former Co-Founder, Women Grow
<h3 class="wp-block-heading">Leah Heise</h3>
Partner at Wolf Meyer and Founder/CEO of Gemini Twin Consulting
<h3 class="wp-block-heading">Luna Stower</h3>
Chief Impact Officer, Ispire Vape Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>)
<h3 class="wp-block-heading">Tai Duncan Atteberry</h3>
VP, Corporate Social Responsibility – Cresco Labs
<h3 class="wp-block-heading">Oludare Odumosu</h3>
Global MD/CEO, Zelira Therapeutics
<h3 class="wp-block-heading">Nicole Miller</h3>
Co-Owner Cultivation, Phyto Group LLC
…and many more.
Get your <a href="https://womengrow.com/tickets/">tickets</a> today.

Cannabis

Events

ISPR

Brittney Griner And Ricky Williams Headline Women Grow 2025 Leadership Summit, Key Event For Cannabis Industry

Guidance

VLCN

Volcon CFO Greg Endo Says "With The Cost Reductions We Have Made And The Anticipated Working Capital Requirements To Fund Inventory Purchases John Notes, We Expect To Be Cash Flow Positive On A Monthly Basis By Q4 Of 2025 And Will Be Able To Fund Operations Into 2026."

Barclays analyst Luke Sergott upgrades Waters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) from Underweight to Equal-Weight and raises the price target from $360 to $415.

Upgrades

Barclays Upgrades Waters to Equal-Weight, Raises Price Target to $415

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SunCar Technology Integrates DeepSeek Into Its Platform

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) adoption is on track to <a href="https://www.benzinga.com/money/will-bitcoin-reach-1-million-a-coin">reach several billion users</a> by the end of the decade, according to Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) CEO Brian Armstrong.
In a <a href="https://x.com/brian_armstrong/status/1888822443873325247">statement</a> on X on Monday, Armstrong pointed to the rapid pace of Bitcoin growth, comparing it to the early adoption rates of mobile phones and the internet.
&#8220;Bitcoin adoption should get to several billion people by 2030 at current rates,&#8221; Armstrong wrote, emphasizing the acceleration in mainstream cryptocurrency use.
He was responding to a tweet by entrepreneur Mario Nawfal, who, citing data from BlackRock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NASDAQ">BLK</a>)stated that crypto adoption has grown 43% faster than mobile phones and 20% faster than the internet.
He said that the report suggests that younger generations, concerns over inflation, and a <a href="https://www.benzinga.com/etfs/specialty-etfs/25/02/43537016/donald-trump-once-said-bitcoin-was-based-on-thin-air-now-his-media-company-is-launching-btc-etf">pro-crypto stance</a> from U.S. leadership are key drivers of this expansion.
Meanwhile, <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43560433/bitcoin-to-hit-between-300000-and-1-5-million-by-2030-ark-invest#:~:text=The%20firm%20outlines%20several%20key,see%20a%20significant%20price%20boost.">institutional adoption</a> continues to grow, with Bitcoin ETFs projected to hit $250 billion in assets under management.
Regulatory clarity is also improving, further legitimizing Bitcoin as a mainstream financial asset.
&#8220;With Bitcoin ETFs projected to hit $250 billion and regulatory wins piling up, crypto's mainstream takeover is accelerating,&#8221; Nawfal said.
As Bitcoin adoption scales, experts see further integration into global finance, driven by both institutional participation and growing retail demand.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43589576/is-solanas-growth-being-held-back-by-a-technical-bottleneck">Is Solana&#8217;s Growth Being Held Back By A Technical Bottleneck?</a>
Why It Matters: Meanwhile, asset management giant BlackRock has increased its stake in Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), a company best known for its <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43568126/blackrock-expands-investment-in-bitcoin-heavy-strategy-reaching-5-ownership">substantial Bitcoin holdings.</a>
A Feb. 6 filing with the U.S. Securities and Exchange Commission (SEC) shows BlackRock now owns approximately 11.26 million shares of Strategy, up from 9.48 million shares three months prior.
This brings BlackRock's total ownership in Strategy to 5%, reflecting an estimated $584 million investment based on Strategy's current share price of $325. 
In total, BlackRock&#8217;s stake is now valued at more than $3.67 billion. 
The company's growing exposure to Strategy aligns with the firm's ongoing accumulation of Bitcoin, which now stands at 471,107 BTC, worth over $46 billion at current prices.
BlackRock's increasing Bitcoin exposure marks a stark shift in the perspective of its CEO, Larry Fink, who once dismissed Bitcoin as an "index of money laundering" and doubted its legitimacy as a financial asset.
However, Fink's stance has significantly changed in recent years, particularly with BlackRock's launch of the iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>). 
He now refers to Bitcoin as a potential &#8220;international asset,&#8221; akin to gold, and sees Bitcoin ETFs as a means to offer <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42998035/bitcoin-adoption-still-early-blackrock-says">regulated access to digital assets. </a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43570466/bitcoin-to-hit-all-time-highs-in-february-under-one-condition-standard-chartered-says">Bitcoin To Hit All-Time Highs In February Under One Condition, Standard Chartered Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

COIN

IBIT

MSTR

Coinbase CEO Brian Armstrong Says Bitcoin Adoption To Reach 'Billions' By 2030

Barclays analyst Luke Sergott upgrades Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) from Underweight to Equal-Weight and raises the price target from $135 to $145.

Barclays Upgrades Agilent Technologies to Equal-Weight, Raises Price Target to $145

Ormand Inds

Comments

Ormand Inds

News

Latest news for Ormand Inds (OTC:OMDD) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga